Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4825591000168118 | Sunlenca (lenacapavir 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4825601000168113 | Sunlenca 300 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sunlenca 300 mg tablet | Is a | Sunlenca | true | Inferred relationship | Some | ||
| Sunlenca 300 mg tablet | Is a | lenacapavir 300 mg tablet | true | Inferred relationship | Some | ||
| Sunlenca 300 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Sunlenca 300 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Sunlenca 300 mg tablet | has Australian BoSS | lenacapavir | true | Inferred relationship | Some | 709792759 | |
| Sunlenca 300 mg tablet | has intended active ingredient | lenacapavir | true | Inferred relationship | Some | 709792759 | |
| Sunlenca 300 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 291448627 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunlenca 300 mg tablet, 5 | has TPUU | True | Sunlenca 300 mg tablet | Inferred relationship | Some | 1875070966 |
| Sunlenca 300 mg tablet, 5, blister pack | has TPUU | True | Sunlenca 300 mg tablet | Inferred relationship | Some | 1123329741 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR